Reactivated DRP1 Enables Resistance to MEK Inhibitors in Pancreatic Cancer Cells
Pancreatic cancer remains notoriously difficult to treat, and targeted therapies often fall short when tumor cells activate escape routes. A ...
Pancreatic cancer remains notoriously difficult to treat, and targeted therapies often fall short when tumor cells activate escape routes. A ...
In a groundbreaking advancement that could reshape future cancer therapies, researchers at Umeå University have unveiled novel insights into the ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine